Cargando…
CAR-T cells targeting CLL-1 as an approach to treat acute myeloid leukemia
BACKGROUND: Acute myeloid leukemia (AML) is one of the most common types of adult acute leukemia. Standard chemotherapies can induce complete remission in selected patients; however, a majority of patients eventually relapse and succumb to the disease. Thus, the development of novel therapeutics for...
Autores principales: | Wang, Jinghua, Chen, Siyu, Xiao, Wei, Li, Wende, Wang, Liang, Yang, Shuo, Wang, Weida, Xu, Liping, Liao, Shuangye, Liu, Wenjian, Wang, Yang, Liu, Nawei, Zhang, Jianeng, Xia, Xiaojun, Kang, Tiebang, Chen, Gong, Cai, Xiuyu, Yang, Han, Zhang, Xing, Lu, Yue, Zhou, Penghui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5761206/ https://www.ncbi.nlm.nih.gov/pubmed/29316944 http://dx.doi.org/10.1186/s13045-017-0553-5 |
Ejemplares similares
-
Cannabis suppresses antitumor immunity by inhibiting JAK/STAT signaling in T cells through CNR2
por: Xiong, Xinxin, et al.
Publicado: (2022) -
Prognostic value of platelet recovery degree before and after achieving minimal residual disease negative complete remission in acute myeloid leukemia patients
por: Wang, Yang, et al.
Publicado: (2020) -
Successful Anti-CLL1 CAR T-Cell Therapy in Secondary Acute Myeloid Leukemia
por: Zhang, Hui, et al.
Publicado: (2020) -
First-in-human phase I study of CLL-1 CAR-T cells in adults with relapsed/refractory acute myeloid leukemia
por: Jin, Xin, et al.
Publicado: (2022) -
Cytotoxic effect of CLL-1 CAR-T cell immunotherapy with PD-1 silencing on relapsed/refractory acute myeloid leukemia
por: Lin, Guoqiang, et al.
Publicado: (2021)